GGrantIndex
← Leaderboards

Cleveland Clinic Lerner Com-Cwru

Cleveland, OH

Compare ↔
$1,944,229,642
Total funding
1,599
Grants

Funding over time

peak $156.3M · FY2006–25
$200M$150M$100M$50M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$1,944,229,642 · 1598
SAMHSA$0 · 1

By mechanism

R01$1,103,508,021 · 646
P01$255,510,561 · 197
U01$154,193,264 · 39
P50$51,111,358 · 52
R21$44,452,232 · 120
P30$31,558,133 · 45

Investigators at Cleveland Clinic Lerner Com-Cwru

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Marisa McGinley$2,484,2842 gr2Deborah Kwon$2,357,0201 gr3Ina Nemet$2,221,2651 gr4Antoine Louveau$2,094,7394 gr5Phuc Le$1,949,7961 gr6Yuxin Wang$1,529,5002 gr7Mandy Miller Koop$1,208,1791 gr8Aaron J Fleischman$1,149,5792 gr

Emerging Leaders

6–10 yrs in

1Feixiong Cheng$10,777,19812 gr2Jagan Ayyappan Pillai$5,603,5106 gr3Jarrod Dalton$4,093,7463 gr4Lara Jehi$4,006,4602 gr5Glen Taksler$3,866,8072 gr6Virendra R Mishra$3,600,5391 gr7Jacob Gardinier Scott$3,455,4341 gr8Pallavi Bhattaram$3,174,1713 gr

All-Time

Most funded here, all years

1Jae U Jung$58,450,52926 gr2Robert Fairchild$22,788,04212 gr3Bruce D Trapp$22,323,5498 gr4Jaroslaw P Maciejewski$20,452,94714 gr5Paul L Fox$18,018,93014 gr6Serpil C. Erzurum$17,940,3328 gr7Kurt P Spindler$17,863,86710 gr8Jay L Alberts$15,319,41113 gr

Largest grants

Assessing Novel Biomarkers for Cognitive Fluctuations in DLB$4,924,374
RF1 · FY2025 · NS
Multi-Omic Biomarkers for Neuropathic Pain Secondary to Chemotherapy$4,775,386
R61 · FY2020 · NS
Pulmonary Vascular Disease Phenomics Program (PVDOMICS) Data Coordinating Center$4,060,500
U01 · FY2017 · HL
Pulmonary Vascular Disease Phenomics Program (PVDOMICS) Data Coordinating Center$4,060,500
U01 · FY2016 · HL
Pulmonary Vascular Disease Phenomics Program (PVDOMICS) Data Coordinating Center$4,060,500
U01 · FY2018 · HL
Pulmonary Vascular Disease Phenomics Program (PVDOMICS) Data Coordinating Center$3,999,591
U01 · FY2015 · HL
Molecular Determinants of Coronary Artery Disease$3,504,536
P50 · FY2009 · HL
Pulmonary Vascular Disease Phenomics Program (PVDOMICS) Data Coordinating Center$3,397,799
U01 · FY2020 · HL
Molecular Determinants of Coronary Artery Disease$3,384,713
P50 · FY2006 · HL
Ibudilast Phase II trial in progressive MS$3,376,514
U01 · FY2014 · NS
Molecular Determinants of Coronary Artery Disease$3,353,613
P50 · FY2008 · HL
Molecular Determinants of Coronary Artery Disease$3,341,961
P50 · FY2007 · HL
Cleveland Clinic Clinical Research Training Program(RMI)$3,158,535
K12 · FY2006 · RR
Ibudilast Phase II trial in progressive MS$3,102,097
U01 · FY2013 · NS
Cleveland Alzheimers Disease Research Center$3,090,243
P30 · FY2021 · AG
Cleveland Alzheimers Disease Research Center$3,078,496
P30 · FY2022 · AG
Cleveland Alzheimers Disease Research Center$3,071,916
P30 · FY2023 · AG
Cleveland Alzheimers Disease Research Center$3,064,013
P30 · FY2024 · AG
Cleveland Alzheimers Disease Research Center$3,062,953
P30 · FY2025 · AG
Atrial Fibrillation Post-GWAS: Mechanisms to Treatment$2,841,649
P01 · FY2022 · HL